enGene Therapeutics Inc. (ENGN)
NASDAQ: ENGN · Real-Time Price · USD
1.820
-0.070 (-3.70%)
At close: Jul 24, 2026, 4:00 PM EDT
1.855
+0.035 (1.92%)
After-hours: Jul 24, 2026, 7:34 PM EDT
enGene Therapeutics Market Cap
enGene Therapeutics has a market cap or net worth of $121.92 million as of July 24, 2026. Its market cap has decreased by -37.38% in one year.
Market Cap
121.92M
Enterprise Value
-103.19M
1-Year Change
-37.38%
Ranking
Category
Stock Price
$1.82
ChartMarket Cap Chart
Since February 1, 2022, enGene Therapeutics's market cap has decreased from $155.91M to $121.92M, a decrease of -21.80%. That is a compound annual growth rate of -5.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 121.92M | -79.84% |
| Dec 31, 2025 | 604.87M | 78.43% |
| Dec 31, 2024 | 338.99M | 58.32% |
| Dec 29, 2023 | 214.12M | 31.08% |
| Dec 30, 2022 | 163.34M | 4.77% |
| Feb 1, 2022 | 155.91M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TuHURA Biosciences | 140.74M |
| Cue Biopharma | 140.54M |
| Connect Biopharma Holdings | 139.15M |
| Aardvark Therapeutics | 132.64M |
| ProMIS Neurosciences | 129.94M |
| Tiziana Life Sciences | 129.31M |
| Genelux | 128.34M |
| Spruce Biosciences | 125.72M |